Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens.
D000617:Aminoglycosides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D001426:Bacterial Proteins / Q000032:analysis; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D008565:Membrane Proteins / Q000032:analysis; D008970:Molecular Weight; D012706:Serratia marcescens / Q000187:drug effects*; D047090:beta-Lactams / Q000627:therapeutic use*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D008565:Membrane Proteins; D047090:beta-Lactams